Better Coronavirus Stock: Moderna vs. Pfizer [The Motley Fool]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: The Motley Fool
Big pharmaceutical companies and small biotechs alike have jumped into the race to develop treatments and vaccines for the novel coronavirus disease COVID-9.Pfizer(NYSE:PFEModernaNASDAQ:MRNAModerna has been the undisputed winner between these two stocks so far in 00. But which of these coronavirus-focused stocks is the better pick for long-term investors?Image source: Getty Images.The case for ModernaIn March, Moderna became the first drugmaker with an experimental COVID-9 vaccine to begin clinical testing in humans in the U.S. The National Institutes of Health (NIH) initiated a phase clinical trial evaluating Moderna's messenger RNA (mRNA) vaccine mRNA-7 in healthy adults.Moderna is preparing to conduct a phase study of mRNA-7 on its own that will build on the data gathered in the NIH-led phase study. In the meantime, the company is making plans to ramp up its manufacturing capabilities to produce millions of doses of the COVID-9 vaccine should clinical testing go well.This first
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna says the FDA will consider its new flu shot after resolving a public dispute [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- FDA backtracks and agrees to review Moderna mRNA flu vaccine after initial rejection [Fortune]Fortune
- FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal [MSNBC.com]MSNBC.com
- Moderna stock surges as FDA reverses course, agrees to review new flu shot [Yahoo! Finance Canada]Yahoo! Finance Canada
- Moderna says the FDA will consider its new flu shot after resolving a public dispute [Yahoo! Finance Canada]Yahoo! Finance Canada
MRNA
Earnings
- 2/13/26 - Beat
MRNA
Sec Filings
- 2/20/26 - Form S-8
- 2/20/26 - Form 10-K
- 2/13/26 - Form 4
- MRNA's page on the SEC website